Endocrine disruptors and reproductive health: the case of bisphenol-A

Mol Cell Endocrinol. 2006 Jul 25:254-255:179-86. doi: 10.1016/j.mce.2006.04.033. Epub 2006 Jun 15.


Epidemiological studies have reported that during the last 60 years the quantity and quality of human sperm has decreased and the incidence of male genital tract defects, testicular, prostate and breast cancer has increased. During the same time period, developmental, reproductive and endocrine effects have also been documented in wildlife species. The last six decades have witnessed a massive introduction of hormonally active synthetic chemicals into the environment leading some to postulate that the diverse outcomes documented in human and wildlife populations might be the result of extemporaneous exposure to xenoestrogens during development. The estrogen-mimic bisphenol-A (BPA) is used as a model agent for endocrine disruption. BPA is used in the manufacture of polycarbonate plastics and epoxy resins from which food and beverage containers and dental materials are made. Perinatal exposure to environmentally relevant BPA doses results in morphological and functional alterations of the male and female genital tract and mammary glands that may predispose the tissue to earlier onset of disease, reduced fertility and mammary and prostate cancer.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Animals
  • Benzhydryl Compounds
  • Dose-Response Relationship, Drug
  • Endocrine Disruptors / adverse effects*
  • Environmental Exposure / adverse effects
  • Fetal Development / drug effects
  • Humans
  • Phenols / adverse effects*
  • Reproduction / drug effects*


  • Benzhydryl Compounds
  • Endocrine Disruptors
  • Phenols
  • bisphenol A